Novel use of antimicrobial hand sanitizer in treatment of nosocomial Acinetobacter infection

Orthopedics

Volumn 32, Issue 1, 2009, Pages 58-

  Donahue, Meghan ^a   Watson, Luke R ^c   Torress Cook, Alfonso ^c   Watson, Paul A ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Lakeside Orthopaedics   (United States)

^c Long Beach Memorial Women's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFEPIME; HAND SANITIZER; LEVOFLOXACIN; STAY BYOTROL CLEAN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; DISINFECTANT AGENT; TOPICAL ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ARTICLE; CASE REPORT; DEBRIDEMENT; DECUBITUS; HOSPITAL INFECTION; HUMAN; MALE; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS; WOUND INFECTION; BACTERIAL SKIN DISEASE; CROSS INFECTION; SKIN DISEASE; SKIN ULCER; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACINETOBACTER INFECTIONS; ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CROSS INFECTION; DISINFECTANTS; HUMANS; LEG DERMATOSES; MALE; SKIN DISEASES, BACTERIAL; SKIN ULCER; TREATMENT OUTCOME;

EID: 65349085572     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20090101-04     Document Type: Article

References (11)

1. Cisneros JM, Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002; 8(11): 687-693.
2. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006; 42(5):692-699.
3. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 1991; 29(2):277-282.
4. Rodríguez-Baño J, Cisneros JM, Fernández-Cuenca F, et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control and Hosp Epidemiol. 2004; 25(10):819-824. (Pubitemid 40036756)
5. Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am J Infect Control. 2002; 30(7):386-390. (Pubitemid 35316421)
6. Van Looveren M, Goossens H, ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect. 2004; 10(8):684-704. (Pubitemid 39232684)
7. Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007; 13(1):97-103.
8. Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004; 130(1):131-141. (Pubitemid 38113927)
9. Gainor BJ, Hockman DE, Anglen JO, Christensen G, Simpson WA. Benzalkonium chloride: a potential disinfecting irrigation solution. J Orthop Trauma. 1997; 11(2):121-125. (Pubitemid 127452354)
10. Tarbox BB, Conroy BP, Malicky ES, et al. Benzalkonium chloride. A potential disinfecting irrigation solution for orthopaedic wounds. Clin Orthop Relat Res. 1998; (346):255-261.
11. Conroy BP, Anglen JO, Simpson WA, et al. Comparison of castile soap, benzalkonium chloride, and bacitracin as irrigation solutions for complex contaminated orthopaedic wounds. J Orthop Trauma. 1999; 13(5):332-337.